z-logo
Premium
Inhibition of caspase‐8 activity promotes protective Th1‐ and Th2‐mediated immunity to Leishmania major infection
Author(s) -
PereiraManfro Wânia F.,
RibeiroGomes Flávia L.,
Filardy Alessandra Almeida,
Vellozo Natália S.,
Guillermo Landi V. C.,
Silva Elisabeth M.,
Siegel Richard M.,
DosReis George A.,
Lopes Marcela F.
Publication year - 2014
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0912463
Subject(s) - biology , blockade , caspase 8 , immunology , leishmania major , apoptosis , immunity , cytokine , caspase , fas ligand , immune system , programmed cell death , leishmania , cancer research , microbiology and biotechnology , receptor , parasite hosting , biochemistry , world wide web , computer science
T cell expression of caspase‐8 inhibitor vFLIP provides a Th1 cytokine environment, along with a protective Th2 response that increases immunity to Leishmania major infection.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom